Binding of purified and radioiodinated capsular polysaccharides from Cryptococcus neoformans serotype A strains to capsule-free mutants
- PMID: 3536747
- PMCID: PMC260232
- DOI: 10.1128/iai.54.3.742-750.1986
Binding of purified and radioiodinated capsular polysaccharides from Cryptococcus neoformans serotype A strains to capsule-free mutants
Abstract
Strains 6, 15, 98, 110, and 145 of Cryptococcus neoformans serotype A vary in capsule size, animal virulence, and susceptibility to in vitro phagocytosis. The isolated capsular polysaccharides (CPSs) differ in monosaccharide composition ratios and molecular size, as determined by gel filtration. The purpose of this investigation was to characterize the binding of CPSs to capsule-free mutants of C. neoformans and to examine CPSs from these strains for differences in their ability to bind, to determine whether such differences might explain the variation in the pathobiology of these strains. CPSs were partially periodate oxidized, tyraminated, iodinated with 125I, and used in binding studies with two capsule-free mutants of C. neoformans, strain 602 and Cap59. Binding was specific for yeast species and for polysaccharide and was saturable, which is consistent with a receptor-mediated mechanism of attachment. Binding occurred rapidly and was only slowly reversible. Binding was also independent of pH from pH 5.5 to 8, of cation concentrations, and of competition by sugars up to 1.0 M concentrations. Only a portion of CPS was capable of binding, and strains varied in the extent to which their CPS bound. CPS-15-IV (peak IV was the major polysaccharide peak on DEAE-cellulose chromatography of CPS from strain 15) had the highest proportion of binding (40%), followed by CPS from strains 98, 6, 145, 110, and 15-III (peak III was an earlier eluting fraction of CPS from strain 15). The CPSs differed similarly in their ability to competitively inhibit binding. Treatment of CPS, but not yeast cells, with proteinase XIV abolished binding without altering the CPS gross structure. Treatment of yeast cells with proteases, heat, or formaldehyde did not alter binding, and both strain 602 and Cap59 bound CPS similarly. Binding to encapsulated yeast cells was minimal.
Similar articles
-
Strain variation in antiphagocytic activity of capsular polysaccharides from Cryptococcus neoformans serotype A.Infect Immun. 1989 Dec;57(12):3751-6. doi: 10.1128/iai.57.12.3751-3756.1989. Infect Immun. 1989. PMID: 2680980 Free PMC article.
-
Strain variation in composition and molecular size of the capsular polysaccharide of Cryptococcus neoformans serotype A.Infect Immun. 1986 Dec;54(3):735-41. doi: 10.1128/iai.54.3.735-741.1986. Infect Immun. 1986. PMID: 3536746 Free PMC article.
-
Binding of cryptococcal polysaccharide to Cryptococcus neoformans.Infect Immun. 1984 Mar;43(3):879-86. doi: 10.1128/iai.43.3.879-886.1984. Infect Immun. 1984. PMID: 6365785 Free PMC article.
-
Cryptococcus neoformans capsule biosynthesis and regulation.FEMS Yeast Res. 2004 Sep;4(8):765-71. doi: 10.1016/j.femsyr.2004.04.003. FEMS Yeast Res. 2004. PMID: 15450183 Review.
-
Role of the capsule in phagocytosis of Cryptococcus neoformans.Rev Infect Dis. 1988 Jul-Aug;10 Suppl 2:S436-9. doi: 10.1093/cid/10.supplement_2.s436. Rev Infect Dis. 1988. PMID: 3055212 Review.
Cited by
-
The Cryptococcus neoformans capsule: a sword and a shield.Clin Microbiol Rev. 2012 Jul;25(3):387-408. doi: 10.1128/CMR.00001-12. Clin Microbiol Rev. 2012. PMID: 22763631 Free PMC article. Review.
-
Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans.Clin Microbiol Rev. 1995 Oct;8(4):515-48. doi: 10.1128/CMR.8.4.515. Clin Microbiol Rev. 1995. PMID: 8665468 Free PMC article. Review.
-
Human natural killer cells do not inhibit growth of Cryptococcus neoformans in the absence of antibody.Infect Immun. 1990 Mar;58(3):639-45. doi: 10.1128/iai.58.3.639-645.1990. Infect Immun. 1990. PMID: 2407651 Free PMC article.
-
Strain variation in antiphagocytic activity of capsular polysaccharides from Cryptococcus neoformans serotype A.Infect Immun. 1989 Dec;57(12):3751-6. doi: 10.1128/iai.57.12.3751-3756.1989. Infect Immun. 1989. PMID: 2680980 Free PMC article.
-
Downregulation by cryptococcal polysaccharide of tumor necrosis factor alpha and interleukin-1 beta secretion from human monocytes.Infect Immun. 1995 Aug;63(8):2919-23. doi: 10.1128/iai.63.8.2919-2923.1995. Infect Immun. 1995. PMID: 7622213 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources